Deregulation of the phosphatase, PP2A is a common event in breast cancer, predicting sensitivity to FTY720

BACKGROUND: The most commonly used biomarkers to predict the response of breast cancer patients to therapy are the oestrogen receptor (ER), progesterone receptor (PgR), and human epidermal growth factor receptor 2 (HER2). Patients positive for these biomarkers are eligible for specific therapies suc...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Baldacchino, Shawn, Saliba, Christian, Petroni, Vanessa, Fenech, Anthony G, Borg, Nigel, Grech, Godfrey
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2014
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3913630/
https://ncbi.nlm.nih.gov/pubmed/24460909
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1878-5085-5-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars